Abingdon Health features in ShareBuyers’ Going for Growth Series

606 Views |

Today Abingdon Health's CEO, Chris Yates, spoke with ShareBuyers, an investor information and news website, about the positive growth prospects for Abingdon Health.

During Chris' interview as part of the ShareBuyers’ Going for Growth series, Chris revealed why he feels Abingdon Health is in a strong place to accommodate the ongoing demand for both COVID and non-COVID lateral flow tests.

To read the interview, read ShareBuyers' article: Abingdon Health on becoming the engine for lateral flow tests

Abingdon Health features in ShareBuyers’ Going for Growth Series

Related content

Manufacturing Agreement with Bioporto A/S(copy)

Are antibody tests the key to reassuring staff that it's safe to return to work?

Manufacturing Agreement with Bioporto A/S

Peer reviewed performance evaluation and self-test user experience of AbC-19™